| Title |
Vedolizumab for induction and maintenance of remission in Crohn’s disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2020
|
| DOI | 10.1002/14651858.cd013611 |
| Authors |
Samuel Hui, Anuj Krishna, Nik Sheng Ding, Ray K Boyapati |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 24 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 4 | 17% |
| Student > Ph. D. Student | 4 | 17% |
| Other | 2 | 8% |
| Student > Master | 2 | 8% |
| Researcher | 2 | 8% |
| Other | 1 | 4% |
| Unknown | 9 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 7 | 29% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 8% |
| Biochemistry, Genetics and Molecular Biology | 2 | 8% |
| Computer Science | 2 | 8% |
| Nursing and Health Professions | 1 | 4% |
| Other | 2 | 8% |
| Unknown | 8 | 33% |